19.04.2016
- As the drug world’s M&A carousel continues to turn, British-Swedish drugmaker Astra Zeneca is being eyed as the latest contender to enter the race to buy US biotech firm Medivation...
16.03.2016
- AstraZeneca shareholders are said to be questioning the £8.4 million pay package awarded to CEO executive Pascal Soriot last year after he successfully deflected a hostile bid from...
18.12.2015
- The third week of December was a busy one for AstraZeneca. Just days after the British-Swedish drugmaker confirmed talks with privately owned biotech Acerta Pharma about an...
07.10.2015
- After a challenging second quarter and first half 2015 – once again marked by foreign exchange turbulence and the impact of acquisitions and divestments – the international...
11.06.2015
- AstraZeneca is mulling whether to independently pursue the developmental psoriasis drug brodalumab after its partner Amgen’s withdrawal from the project in May, Pascal Soriot...
13.03.2015
- Both European and US pharmaceutical industry players are highly research-oriented and possess very diversified portfolios. While each country has its national champions, Swiss...
08.05.2014
- In contrast to chemicals, the global pharmaceutical industry is little plagued by market cyclicality or general economic swings. But it faces equally daunting challenges, as the...
01.10.2013
- Fixing ailing drugmaker AstraZeneca remains a work in progress for Chief Executive Pascal Soriot, with sales and profits still heading firmly downhill after his first year in the...
